PHANES THERAPEUTICS INC has a total of 83 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are POMONA RICERCA SRL, SINOMAB BIOSCIENCE LTD and INST ANTIBODIES CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 13 | |
#2 | Australia | 9 | |
#3 | Canada | 9 | |
#4 | EPO (European Patent Office) | 9 | |
#5 | Republic of Korea | 9 | |
#6 | United States | 9 | |
#7 | China | 8 | |
#8 | Brazil | 6 | |
#9 | Singapore | 6 | |
#10 | Israel | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Wang Minghan | 72 |
#2 | Zou Hui | 72 |
#3 | Jia Haiqun | 42 |
#4 | Oaks Joshua | 15 |
#5 | Pei Fen | 8 |
#6 | Tam Arvin | 8 |
#7 | Hui Zou | 6 |
#8 | Minghan Wang | 6 |
#9 | Haiqun Jia | 4 |
#10 | Fen Pei | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021003082A1 | Anti-claudin 18.2/anti-cd47 bispecific antibodies and uses thereof | |
WO2020210247A1 | Humanized anti-folate receptor 1 chimeric antigen receptors and uses thereof | |
WO2020210067A1 | Humanized anti-dll3 chimeric antigen receptors and uses thereof | |
WO2020205331A1 | Humanized anti-claudin 18.2 chimeric antigen receptors and uses thereof | |
AU2019267349A1 | Anti-DLL3 antibodies and uses thereof | |
KR20200132900A | Anti-folate receptor 1 antibody and uses thereof | |
CA3089649A1 | Anti-tip-1 antibodies and uses thereof | |
CN111836644A | Anti-claudin 18.2 antibodies and uses thereof | |
CN111867628A | anti-CD 73 antibodies and uses thereof | |
WO2019046225A1 | Anti-lag-3 antibodies and uses thereof | |
EP3672987A1 | Anti-apelin antibodies and uses thereof | |
KR20200033948A | Anti-CD47 antibodies and uses thereof | |
KR20200032156A | Anti-TIM-3 antibodies and uses thereof |